Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 26 studies | 48% ± 18% | |
astrocyte | 19 studies | 50% ± 19% | |
fibroblast | 17 studies | 48% ± 21% | |
microglial cell | 16 studies | 56% ± 16% | |
oligodendrocyte | 15 studies | 38% ± 16% | |
smooth muscle cell | 13 studies | 48% ± 18% | |
macrophage | 13 studies | 37% ± 16% | |
oligodendrocyte precursor cell | 13 studies | 42% ± 13% | |
glutamatergic neuron | 12 studies | 61% ± 23% | |
pericyte | 12 studies | 50% ± 19% | |
GABAergic neuron | 11 studies | 58% ± 23% | |
adipocyte | 10 studies | 70% ± 18% | |
mast cell | 8 studies | 34% ± 11% | |
mesothelial cell | 8 studies | 55% ± 24% | |
endothelial cell of lymphatic vessel | 8 studies | 41% ± 17% | |
epithelial cell | 7 studies | 50% ± 22% | |
B cell | 7 studies | 40% ± 13% | |
basal cell | 7 studies | 52% ± 29% | |
neuron | 6 studies | 45% ± 21% | |
T cell | 6 studies | 35% ± 15% | |
kidney loop of Henle epithelial cell | 5 studies | 47% ± 37% | |
retinal ganglion cell | 5 studies | 55% ± 27% | |
cardiac muscle cell | 5 studies | 49% ± 13% | |
dendritic cell | 5 studies | 35% ± 9% | |
myeloid cell | 5 studies | 34% ± 10% | |
ciliated cell | 5 studies | 37% ± 13% | |
club cell | 5 studies | 54% ± 20% | |
monocyte | 5 studies | 32% ± 11% | |
type I pneumocyte | 5 studies | 62% ± 7% | |
type II pneumocyte | 5 studies | 60% ± 9% | |
interneuron | 5 studies | 65% ± 26% | |
cholangiocyte | 4 studies | 67% ± 9% | |
hepatocyte | 4 studies | 67% ± 24% | |
glial cell | 4 studies | 34% ± 8% | |
granule cell | 4 studies | 39% ± 16% | |
retinal pigment epithelial cell | 4 studies | 67% ± 25% | |
Mueller cell | 4 studies | 66% ± 19% | |
amacrine cell | 4 studies | 45% ± 22% | |
retinal cone cell | 4 studies | 36% ± 11% | |
retinal rod cell | 4 studies | 48% ± 12% | |
endothelial cell of vascular tree | 4 studies | 40% ± 15% | |
muscle cell | 4 studies | 45% ± 20% | |
abnormal cell | 4 studies | 34% ± 22% | |
hepatic stellate cell | 3 studies | 51% ± 19% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 47% ± 3% | |
GABAergic interneuron | 3 studies | 49% ± 19% | |
progenitor cell | 3 studies | 35% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 26% ± 2% | |
vein endothelial cell | 3 studies | 46% ± 17% | |
GABAergic amacrine cell | 3 studies | 36% ± 15% | |
OFF-bipolar cell | 3 studies | 39% ± 2% | |
ON-bipolar cell | 3 studies | 49% ± 11% | |
glycinergic amacrine cell | 3 studies | 38% ± 10% | |
retina horizontal cell | 3 studies | 35% ± 9% | |
neural progenitor cell | 3 studies | 49% ± 25% | |
ependymal cell | 3 studies | 59% ± 13% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 37% ± 8% | |
alveolar macrophage | 3 studies | 40% ± 5% | |
capillary endothelial cell | 3 studies | 41% ± 4% | |
endothelial cell of artery | 3 studies | 45% ± 10% | |
myofibroblast cell | 3 studies | 44% ± 19% | |
natural killer cell | 3 studies | 23% ± 7% | |
respiratory goblet cell | 3 studies | 53% ± 20% | |
leukocyte | 3 studies | 57% ± 13% | |
epithelial cell of proximal tubule | 3 studies | 55% ± 26% | |
renal principal cell | 3 studies | 71% ± 33% | |
mucus secreting cell | 3 studies | 46% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 644.70 | 245 / 245 | 100% | 14.59 | 502 / 502 |
kidney | 100% | 902.65 | 89 / 89 | 100% | 16.34 | 899 / 901 |
ovary | 100% | 700.37 | 180 / 180 | 100% | 8.72 | 428 / 430 |
liver | 100% | 356.90 | 226 / 226 | 100% | 12.09 | 404 / 406 |
thymus | 100% | 780.92 | 653 / 653 | 99% | 15.24 | 601 / 605 |
breast | 100% | 654.64 | 459 / 459 | 99% | 8.81 | 1110 / 1118 |
pancreas | 99% | 292.70 | 326 / 328 | 99% | 6.85 | 177 / 178 |
skin | 100% | 386.61 | 1806 / 1809 | 99% | 14.50 | 466 / 472 |
brain | 97% | 226.07 | 2572 / 2642 | 100% | 9.32 | 703 / 705 |
adrenal gland | 100% | 573.89 | 258 / 258 | 97% | 8.04 | 222 / 230 |
bladder | 100% | 546.52 | 21 / 21 | 96% | 7.48 | 483 / 504 |
intestine | 100% | 472.53 | 964 / 966 | 96% | 7.93 | 506 / 527 |
lung | 99% | 346.77 | 574 / 578 | 96% | 6.28 | 1113 / 1155 |
uterus | 100% | 579.59 | 170 / 170 | 94% | 6.36 | 433 / 459 |
stomach | 100% | 405.04 | 359 / 359 | 92% | 6.88 | 263 / 286 |
esophagus | 100% | 479.58 | 1445 / 1445 | 84% | 3.74 | 153 / 183 |
adipose | 100% | 597.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 734.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.03 | 1 / 1 |
muscle | 100% | 525.04 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 242.55 | 240 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 8.70 | 79 / 80 |
heart | 97% | 277.73 | 837 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 5.41 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 89% | 3.64 | 40 / 45 |
peripheral blood | 25% | 75.53 | 231 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006465 | Biological process | signal peptide processing |
GO_0007420 | Biological process | brain development |
GO_0006974 | Biological process | DNA damage response |
GO_0061300 | Biological process | cerebellum vasculature development |
GO_0033108 | Biological process | mitochondrial respiratory chain complex assembly |
GO_0008015 | Biological process | blood circulation |
GO_0030728 | Biological process | ovulation |
GO_0006801 | Biological process | superoxide metabolic process |
GO_0007283 | Biological process | spermatogenesis |
GO_0022904 | Biological process | respiratory electron transport chain |
GO_0001541 | Biological process | ovarian follicle development |
GO_0006627 | Biological process | protein processing involved in protein targeting to mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0042720 | Cellular component | mitochondrial inner membrane peptidase complex |
GO_0008233 | Molecular function | peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | IMMP2L |
Protein name | Mitochondrial inner membrane protease subunit 2 (IMP2-like protein) Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein) Inner mitochondrial membrane peptidase subunit 2 Mitochondrial inner membrane protease subunit (EC 3.4.21.-) |
Synonyms | hCG_2039401 tcag7.50 |
Description | FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . |
Accessions | ENST00000450877.5 ENST00000405709.7 [Q96T52-1] ENST00000437687.2 Q96T52 ENST00000452895.5 [Q96T52-1] C9JQE1 A0A0C4DG32 ENST00000452753.1 A4D0S9 C9JVB0 ENST00000331762.7 [Q96T52-1] ENST00000447215.5 [Q96T52-2] |